How to Get the Most Out of Mesothelioma Immunotherapy
For patients with mesothelioma, there is a lot of excitement surrounding cancer immunotherapy.
Some ongoing clinical trials suggest immunotherapy may be more effective for treating mesothelioma than standard chemotherapy treatment.
For immunotherapy to work well, the patient needs to have a healthy immune system. In general, the healthier the immune system, the more likely a patient will respond favorably to immunotherapy treatments.
Ongoing immunotherapy research also suggests the microbiome, which is the community of microbes living on and in our bodies, can affect how well immunotherapy treatments work.
What Is the Microbiome?
The microbiome refers to the trillions of bacteria, viruses, fungi and other microbes that inhabit the human body.
We tend to consider bacteria and viruses as harmful to health. While it’s true they can cause colds, the flu and other miseries, not all microbes are harmful.
In fact, the microbes in the human microbiome play an important role in maintaining our well-being. For example, the microbiome in our gut plays a critical role in how the immune system works.
Some health experts even consider the gut microbiome a part of the immune system. Without a healthy gut microbiome, our immune systems do not function well.
In recent years, researchers have become more interested in how the microbiome affects cancer treatment, including immunotherapy.
Immunotherapy and Microbiome Research
Most of the microbiome-immunotherapy research has involved mice and rats. These studies point to the importance of having a rich variety of gut bacteria for immunotherapy to work well.
But a 2017 microbiome-immunotherapy analysis in human patients with melanoma agrees with the animal research.
For the melanoma study, the researchers examined the gut microbiome of 112 patients with advanced melanoma. All patients received immunotherapy called anti-PD-1 therapy.
PD-1 (programmed cell death-1) is a protein made by cancer cells that prevents a person’s immune system from killing cancer cells. Current mesothelioma clinical trials are studying how to block the protein and allow the immune system to destroy cancer cells without harming healthy cells.
Participants with a greater variety of gut bacteria at the start of the melanoma investigation were more likely to respond well to treatment. A good response meant their tumors decreased in size, disappeared or stabilized for at least six months.
The participants with a less diverse microbiome — one that includes fewer types of gut bacteria — were more likely to experience tumor growth during treatment. Their disease also stabilized for fewer than six months.
In summary: The wider the variety of bacteria inside the gut, the better the patients responded to immunotherapy.
Mesothelioma Patients May Benefit from the Microbiome
Anti-PD-1 immunotherapies currently being studied in mesothelioma clinical trials include:
Keytruda is the focus of an ongoing trial in six countries. These drugs are the same types of medication studied in melanoma patients.
The melanoma study does not prove cause and effect. It does suggest more variety in the microbiome could support a better response to immunotherapy for people with mesothelioma and other cancers.
Maintaining a Healthy Microbiome
Certain diet and lifestyle choices support a more diverse gut microbiome. A richer gut microbiome may support the body’s healthy response to immunotherapy.
The following steps support a varied and healthy microbiome:
- Eat microbiome-friendly foods such as vegetables, fruit, nuts, seeds, beans, peas and whole grains.
- Eat fermented foods such as yogurt, kefir and sauerkraut.
- Get enough sleep. Most experts recommend between seven and nine hours of sleep per night and keeping consistent sleeping and waking hours.
- Move your body every day. Avoid sitting for hours and enjoy daily physical activity such as walking.
- Maintain a healthy body weight.
For healthier gut bacteria, experts also advise avoiding artificial sweeteners and taking antibiotics only when needed. They also recommend eating more high-fiber foods such as oatmeal, apples, bananas, broccoli, lentils and other edible plants.
These nutrition tips may not be appropriate for some mesothelioma patients during treatment.
Talk to your doctor or dietitian if you are losing weight without trying or have questions about your diet before, during or after mesothelioma treatment.
Share This Article
16 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
Akst, J. (2017, September 20). In-Depth Look at the Human Microbiome. The Scientist, 31.
Retrieved from: https://www.the-scientist.com/?articles.view/articleNo/50376/title/In-Depth-Look-at-the-Human-Microbiome/
Grens, K. (2017, December 5). Microbes of the Human Tongue Form Organized Clusters. The Scientist, 31.
Retrieved from: https://www.the-scientist.com/?articles.view/articleNo/51098/title/Microbes-of-the-Human-Tongue-Form-Organized-Clusters/
Collins, D. et al. (2011). Microbial and viral pathogens in colorectal cancer. Lancet Oncol, 12, 504-12. doi: 10.1016/S1470-2045(10)70186-8
Marinell, L. et al. (2017). Probiotic species in the modulation of the anticancer immune response. Seminars in Cancer Biology, 46, 182-90.
Retrieved from: http://www.sciencedirect.com/science/article/pii/S1044579X17302122?via%3Dihub
Doki, N. et al. (2017). Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation. Annals of Hematology, 96, 1517-23.
Golob, J.L. et al. (2017, December 15). Stool microbiota at neutrophil recovery is predictive for severe acute graft vs host disease after hematopoietic cell transplantation. Clinical Infectious Diseases, 65, 1984-91.
Retrieved from: https://academic.oup.com/cid/article/65/12/1984/4085173
National Cancer Institute. (2015, May 15). NCI Dictionary of Cancer Terms.
Retrieved from: https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46066
Vétizou, M. et al. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science, 350, 1079-84. DOI: 10.1126/science.aad1329
Sivan, A. et al. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science, 350, 1084-9. DOI: 10.1126/science.aac4255
Routy, B. et al. (2017, November 2). Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, DOI: 10.1126/science.aan3706
Gopalakrishnan, V. et al. (2017, November 2). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, DOI: 10.1126/science.aan4236
Lozupone, C.A. et al. (2012, September 13). Diversity, stability and resilience of the human gut microbiota. Nature, 489, 220–30, DOI: 10.1038/nature11550
Parekh, P.J. et al. (2017, December 4). The Effects of Sleep on the Commensal Microbiota: Eyes Wide Open? J Clin Gastroenterol, DOI: 10.1097/MCG.0000000000000965
Codella, R. et al. (2017, November 28). Exercise has the guts: How physical activity may positively modulate gut microbiota in chronic and immune-based diseases. Dig Liver Dis, pii: S1590-8658(17)31312-9, DOI: 10.1016/j.dld.2017.11.016
Cotillard, A. et al. (2013, August 29). Dietary intervention impact on gut microbial gene richness. Nature, 500, 585-88. DOI: 10.1038/nature12480
- Nettleton et al. (2016, October 1). Reshaping the gut microbiota: Impact of low calorie sweeteners and the link to insulin resistance? Physiology & Behavior, 164, 488-93, DOI: 10.1016/j.physbeh.2016.04.029